1-2 of 2
Stefanie Biedermann
Close
Sort by
Journal Articles

Characterization and T-Cell Repertoire of MB-CART2019.1 (Zamtocabtagene autoleucel) - Data from the Phase I Trial in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Tatjana Holzer, Stefanie Biedermann, Inga Herfort, Birte Friedrichs, Silke Holtkamp, Linda Hanssens, Mario Assenmacher, Ulf Bethke, Dina Schneider, Stefan Miltenyi, Toon Overstijns, Christoph Schmid, Francis A. Ayuk, Christoph Scheid, Anja Jühling, Udo Holtick, Philipp Gödel, Peter Borchmann, Iris Bürger
Journal: Blood
Blood (2022) 140 (Supplement 1): 4581–4583.
https://doi.org/10.1182/blood-2022-164597
Published: 2022
Journal Articles

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Peter Lang, MD, Rupert Handgretinger, MD PhD, Roland Meisel, MD, Stephan Mielke, MD, Dietger Niederwieser, MD, Paul G. Schlegel, MD, Johann Greil, MD, Ansgar Schulz, MD, Peter Bader, MD PhD, Arne Brecht, MD, Donald Bunjes, MD, Jurgen Kuball, MD, Michael Schumm, Dr. MD vet., Matthias K. Eyrich, MD, Vladan Vucinic, MD, Markus Wiesneth, MD, Halvard Bonig, MD MA, Kasper Westinga, BSc, Sandra Karitzky, PhD, Silke Holtkamp, Michaela Malchow, PhD, Christiane Siewert, PhD, Stefanie Biedermann, Wolfgang Bethge, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 604.
https://doi.org/10.1182/blood-2018-99-110124
Published: 2018